Targeting cyclin-dependent kinases offers new pathways for cancer therapy
Cancer is the second leading cause of death in Germany. In the search for new therapeutic approaches that…
Insilico Medicine highlights AI-powered biological target discovery for rare sinonasal cancer
Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven biotechnology company, today announced the publication of a collaborative…
7 life-saving medical innovations that could redefine healthcare
Over the past few years, several innovations have crossed important milestones, moving from experimental concepts toward real-world patient…
Blue LED lights help chemists build complex drug molecules
In drug discovery, building complex molecules quickly is the name of the game. Chemists want molecules with increasingly…
Middle East Erupts Again: Buy these Healthcare ETFs Before the Next Strike
The global geopolitical landscape has plunged into a deep state of uncertainty once again following a direct exchange…
New antibiotic kills drug-resistant bacteria by targeting a previously unknown vulnerability
Researchers at McMaster University have discovered a new antibiotic that kills some of the world’s most dangerous and…
Dual-pathway protein degradation approach could improve cancer treatment
Targeted protein degradation has become one of the most promising strategies in modern drug discovery, enabling scientists to…
INDIGO Biosciences expands reporter assay capabilities with new Transrepression Assay Services
INDIGO Biosciences today announced the launch of its Transrepression Assay Services, expanding the company’s cell-based reporter assay capabilities…
New AI tool can generate millions of new molecules
Chemists have long faced a maddening problem. The number of possible useful molecules is so vast that even…
GLP-1R–GIPR–PPARα/γ/δ quintuple agonism corrects obesity and diabetes in mice
Animals and housing conditions Experiments were performed in accordance with the Animal Protection Law of the European Union…
OICR funds four Ontario teams to develop next-generation cancer therapies
Better cancer care depends on better treatment options. That’s why the Ontario Institute for Cancer Research (OICR) is…
New drugs take aim at one of cancer’s deadliest mutations
A form of pancreatic cancer (pictured) is often caused by mutations in the KRAS protein.Credit: PJD/Science Photo Library…